KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cerence (CRNC) Cash & Equivalents (2019 - 2025)

Historic Cash & Equivalents for Cerence (CRNC) over the last 7 years, with Q3 2025 value amounting to $84.0 million.

  • Cerence's Cash & Equivalents fell 3084.17% to $84.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $84.0 million, marking a year-over-year decrease of 3084.17%. This contributed to the annual value of $84.0 million for FY2025, which is 3084.17% down from last year.
  • Per Cerence's latest filing, its Cash & Equivalents stood at $84.0 million for Q3 2025, which was down 3084.17% from $73.7 million recorded in Q2 2025.
  • Cerence's Cash & Equivalents' 5-year high stood at $128.4 million during Q3 2021, with a 5-year trough of $17.7 million in Q2 2022.
  • Over the past 5 years, Cerence's median Cash & Equivalents value was $101.2 million (recorded in 2023), while the average stood at $99.9 million.
  • In the last 5 years, Cerence's Cash & Equivalents plummeted by 8533.85% in 2022 and then surged by 38597.39% in 2023.
  • Quarter analysis of 5 years shows Cerence's Cash & Equivalents stood at $117.2 million in 2021, then dropped by 22.67% to $90.7 million in 2022, then rose by 8.91% to $98.7 million in 2023, then rose by 5.44% to $104.1 million in 2024, then dropped by 19.29% to $84.0 million in 2025.
  • Its Cash & Equivalents was $84.0 million in Q3 2025, compared to $73.7 million in Q2 2025 and $117.4 million in Q1 2025.